|
| 36757946 | A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms. | PLoS One | 2023 |
| 37711632 | Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability. | Front Immunol | 2023 |
| 37579513 | Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population. | Emerg Infect Dis | 2023 |
| 35608504 | Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines. | Clin Infect Dis | 2023 |
| 36652247 | Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection. | JAMA Netw Open | 2023 |
| 36940347 | Impact of Nonpharmaceutical Interventions During the COVID-19 Pandemic on Medically Attended Acute Respiratory Infection: The U.S. Naval Academy Experience. | Mil Med | 2023 |
| 35134203 | Respiratory Infections Are More Common Than Healthcare Records Indicate: Results From an Anonymous Survey. | Mil Med | 2022 |
| 35380448 | SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies. | Sci Transl Med | 2022 |
| 36442063 | Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. | Ann Intern Med | 2022 |
| 35873301 | COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health. | Open Forum Infect Dis | 2022 |
| 36275868 | Influenza Vaccine Effectiveness: Analysis of the Impact of Repeated Vaccinations in Military Health System Beneficiaries. | Open Forum Infect Dis | 2022 |
| 35899278 | An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection. | Open Forum Infect Dis | 2022 |
| 36267247 | Breath Biomarkers of Influenza Infection. | Open Forum Infect Dis | 2022 |
| 36356586 | Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history. | Cell Host Microbe | 2022 |
| 36251675 | Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection. | PLoS One | 2022 |
| 35203111 | Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers. | Emerg Infect Dis | 2022 |
| 35198647 | Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers. | Open Forum Infect Dis | 2022 |
| 32949240 | A Case of Early Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). | Clin Infect Dis | 2021 |
| 33594376 | Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses. | medRxiv | 2021 |
| 33893210 | Effects of human immunodeficiency virus status on symptom severity in influenza-like illness in an otherwise healthy adult outpatient cohort. | J Investig Med | 2021 |
| 33661864 | SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020. | MMWR Morb Mortal Wkly Rep | 2021 |
| 33553482 | SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic. | Open Forum Infect Dis | 2021 |
| 34981057 | SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster. | bioRxiv | 2021 |
| 34909439 | COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment. | Open Forum Infect Dis | 2021 |
| 34877361 | Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19. | Open Forum Infect Dis | 2021 |
| 35141345 | Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection. | Open Forum Infect Dis | 2021 |
| 34901299 | Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019. | Open Forum Infect Dis | 2021 |
| 35047649 | Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers. | Open Forum Infect Dis | 2021 |
| 34673956 | Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection. | J Infect Dis | 2021 |
| 34107889 | Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. | BMC Infect Dis | 2021 |
| 34230937 | Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers. | medRxiv | 2021 |
| 34331541 | Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries. | J Infect Dis | 2021 |
| 33306283 | Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. | N Engl J Med | 2021 |
| 32898271 | Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin. | Clin Infect Dis | 2021 |
| 31296963 | Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancer. | Cell Death Differ | 2020 |
| 33269345 | A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions. | Res Sq | 2020 |
| 33176077 | An Outbreak of Covid-19 on an Aircraft Carrier. | N Engl J Med | 2020 |
| 32588899 | Comparable Disease Severity by Influenza Virus Subtype in the Acute Respiratory Infection Consortium Natural History Study. | Mil Med | 2020 |
| 32445440 | Remdesivir for the Treatment of Covid-19 - Final Report. | N Engl J Med | 2020 |
| 30926957 | New filovirus disease classification and nomenclature. | Nat Rev Microbiol | 2019 |
| 31778201 | The US Military HIV Natural History Study: Informing Military HIV Care and Policy for Over 30 Years. | Mil Med | 2019 |
| 31778200 | Infectious Disease Clinical Research Program: Future Direction. | Mil Med | 2019 |
| 31778197 | The Infectious Disease Clinical Research Program: Overview. | Mil Med | 2019 |
| 31778194 | The Acute Respiratory Infection Consortium: A Multi-Site, Multi-Disciplinary Clinical Research Network in the Department of Defense. | Mil Med | 2019 |
| 31217351 | Effect of HIV infection and antiretroviral therapy on immune cellular functions. | JCI Insight | 2019 |
| 29350887 | Species-specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults. | Influenza Other Respir Viruses | 2018 |
| 30019003 | Human Serum With High Neutralizing Antibody Titers Against Both Zika and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue Virus Infection. | Open Forum Infect Dis | 2018 |
| 29477403 | Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients. | Value Health | 2018 |
| 29566007 | Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI). | PLoS One | 2018 |
| 29153266 | Ebola virus disease: an update on post-exposure prophylaxis. | Lancet Infect Dis | 2018 |